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Recent genome-wide studies have demonstrated
that pausing of RNA polymerase II (Pol II) occurred
on many vertebrate genes. By genetic studies in
the zebrafish tif1g mutant moonshine we found that
loss of function of Pol II-associated factors PAF or
DSIF rescued erythroid gene transcription in tif1g-
deficient animals. Biochemical analysis established
physical interactions among TIF1g, the blood-
specific SCL transcription complex, and the positive
elongation factors p-TEFb and FACT. Chromatin
immunoprecipitation assays in human CD34+ cells
supported a TIF1g-dependent recruitment of posi-
tive elongation factors to erythroid genes to promote
transcription elongation by counteracting Pol II
pausing. Our study establishes a mechanism for
regulating tissue cell fate and differentiation through
transcription elongation.INTRODUCTION
Vertebrate hematopoiesis defines an evolutionarily conserved
hierarchy in which self-renewing hematopietic stem cells
(HSCs) progressively differentiate into multilineage blood cells
(Orkin and Zon, 2008). Forward genetic screens in zebrafish
have identified many mutants affecting the erythroid lineage
(Ransom et al., 1996; Weinstein et al., 1996). We previously char-
acterized the defective gene in moonshine (mon), a mutant with
a profound anemia and embryonic lethality (Ransom et al., 1996).
mon gene encodes the zebrafish ortholog of Transcriptional
Intermediary Factor 1gamma (tif1g) (Ransom et al., 2004), a ubiq-
uitously expressed gene that is highly enriched in blood tissues.
The primitive erythroid lineage is normally specified in mon
mutants but rapidly lost in developing embryos. Rare adult
mon survivors (1/500) are extremely anemic, suggesting anessential function of tif1g in definitive erythropoiesis as well
(Ransom et al., 2004).
The four members in TIF1 family, TIF1a, b, g, and d, are nuclear
proteins composed of multiple evolutionarily conserved domains
implicated in protein-protein interaction and chromatin associa-
tion, including an N-terminal RBCC or TRIM domain, and the
C-terminal PHD finger and bromodomain (Khetchoumian et al.,
2004). At the molecular level, TIF1a and b function as transcrip-
tion cofactors for nuclear hormone receptors and KRAB zinc-
finger transcription factors, respectively (Friedman et al., 1996;
Kim et al., 1996; Le Douarin et al., 1996). In contrast, the molec-
ular function of TIF1g remains controversial. He et al. found that
TIF1g mediates TGFb signaling by interacting with phosphory-
lated Smad2/3 (He et al., 2006), whereas Dupont et al. showed
that TIF1g inhibits TGFb/BMP signaling by monoubiquitinating
Smad4 (Dupont et al., 2005, 2009).
Hematopoietic gene expression has been extensively studied
at the transcription initiation step that is controlled by cell-
specific transcription complexes composed of SCL, LMO2,
GATA1, and many other cofactors (Meier et al., 2006; Schuh
et al., 2005; Wadman et al., 1997). In addition to transcription
initiation, recent genome-wide studies have discovered
a commonly occurred pausing/stalling of RNA polymerase II
(Pol II) in eukaryotic genomes, suggesting transcription elonga-
tion as a critical step in gene regulation (Guenther et al., 2007;
Muse et al., 2007; Zeitlinger et al., 2007). Studies on transcription
elongation have shown that both negative and positive factors
regulate elongation. Negative elongation factors DSIF (DRB
Sensitivity Inducing Factor) and NELF (Negative Elongation
Factor) stall Pol II at the proximal promoter (Wu et al., 2003;
Yamaguchi et al., 2002), whereas the positive elongation factor
p-TEFb is required to release paused Pol II by phosphorylating
the CTD domain of Pol II (Cheng and Price, 2007; Peterlin and
Price, 2006). Pol II elongation is tightly linked to chromatin
modification. The PAF (Pol II Associated Factor) complex asso-
ciates with the elongating Pol II and recruits enzymes for histone
2B ubiquitination (Pokholok et al., 2002; Wood et al., 2003). The
histone chaperone FACT (Facilitates Chromatin Transcription)
complex is required for nucleosome assembly during Pol IICell 142, 133–143, July 9, 2010 ª2010 Elsevier Inc. 133
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Figure 1. Genetic Suppressor Screen in the
mon Mutant
(A) Scheme of generating viable mon transgenic
fish using a BAC transgene.
(B) Scheme of the suppressor screen. BAC
transgenic fish are green fluorescent. In F1 gener-
ation, three groups of embryos were obtained:
transgene homozygous (mon; Tg/Tg), transgene
heterozygous (mon; Tg/+), and embryos with no
transgene (mon). Only transgene heterozygous
(in the red circle) were raised up to adults. Double
in situ hybridization of GFP and be3 globin was
performed on F2 haploid embryos. Note the GFP
staining on mon; Tg haploids (strong in the head
and weak throughout the body) but not on
haploids lacking the transgene. ‘‘sup’’ indicates a
suppressor mutation.
(C) Morphology of the sunrise mutant at 48 hpf.
(D) In situ hybridization of be3 globin at 22 hpf.
See also Figure S1.elongation and also facilitates the recruitment of p-TEFb
(Saunders et al., 2003; Wada et al., 2000). Regulation of Pol II
elongation has also been implicated in blood gene expression.
Sawado et al. found that the locus control region (LCR) of murine
b-globin gene regulates the transition from the transcription initi-
ation to elongation (Sawado et al., 2003). A study from Elagib
et al. suggested an involvement of p-TEFb in megakaryocyte
differentiation (Elagib et al., 2008).
In an effort to understand the role of TIF1g in regulating eryth-
ropoiesis, we undertook a genetic modifier screen to look for
suppressor mutants that could bypass TIF1g and rescue the
erythroid defect in mon mutants. One suppressor mutant,
sunrise, has a mutation in cdc73 gene, which encodes a subunit
of the elongation factor PAF. Genetic studies revealed a func-
tional antagonism between TIF1g and PAF/DSIF elongation
factors in regulating erythroid gene expression. Biochemical
studies in human cells demonstrated a direct link between134 Cell 142, 133–143, July 9, 2010 ª2010 Elsevier Inc.TIF1g and the transcription elongation
machinery, and supported a model in
which TIF1g couples the blood-specific
transcriptional complex with Pol II elon-
gation machinery to promote the tran-
scription elongation of erythroid genes
by counteracting Pol II pausing. Our study
illustrates a critical developmental check-
point in which cell-specific transcription
factors interacts with the elongation
machinery to regulate cell fate.
RESULTS
Genetic Suppressor Screen
in the Zebrafish mon Mutant
In order to identify genetic pathways in-
teracting with TIF1g during hematopoi-
esis, we conducted a genetic modifier
screen to identify suppressor mutantsthat rescue the blood defect in mon embryos. The vast majority
of mon homozygous fish die at approximately 7 to 10 days post
fertilization (dpf), making it difficult to perform a genetic screen.
Therefore, we created a viable mon homozygous line using
a bacterial artificial chromosome (BAC) transgene (Figure 1A).
This 168 kb zebrafish BAC clone contains the entire tif1g gene
locus. A green fluorescent protein (GFP) marker driven by the
b-actin promoter was recombined onto the backbone of BAC.
After establishing stable transgenic lines, we confirmed that
a single copy of the transgene could fully rescue mon homozy-
gous fish to adulthood with normal blood development.
Using this transgenic line, we undertook a haploid screen to
identify suppressor mutants (Figure 1B). ENU (N-ethyl-N-nitro-
sourea) mutagenesis was performed on males that were homo-
zygous for mon and carried one copy of the transgene (mon;
Tg{Tif1g+; bactin:GFP}/+). F1 females were used to produce
haploid embryos that were subjected to double in situ
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Figure 2. The Defective Gene in sunrise Is
cdc73
(A) The sunrise locus was mapped on chromo-
some 2 between the microsatellite marker
z19837 and z13475. The cdc73 gene is located
within this region.
(B) The morphology of wild-type, sun mutant, and
rtf1/ mutant at 36 hpf. Injection of cdc73
mRNA completely (12 out of 12 embryos) rescued
the morphology of sun mutants.
(C) DNA sequence chromatograms showing the
C/ T transition at +1507 in cdc73 coding region
in sun homozygous mutant, leading to a premature
stop codon (in the red box).
(D) Alignment of the C-terminal CDC73 protein
sequence from Drosophila, human, and zebrafish.
The nonsense mutation in sun mutant is indicated
by a red arrow.
(E) Western blot showing the loss of CDC73
protein in sun mutant. Protein was extracted from
36 hpf embryos. Red asterisk: zebrafish CDC73
(64 kDa). Black asterisk: nonspecific bands.
Actin is used as a loading control.
(F) Morpholino (MO)-mediated knockdown of
cdc73 completely rescues globin expression
in mon (22 out of 22 embryos), whereas
5 bp mismatch control morpholino has no rescue
(0 out of 13 embryos).hybridization for GFP and be3 globin at 22 hr post fertilization
(hpf). During the screen, most F1 females did not carry
suppressor mutations and gave rise to embryo clutches that
contain only double-positive (GFP+; be3+) and double-negative
(GFP-; be3-) embryos. If a female carried a suppressor mutation
that could restore be3 globin expression in the absence of tif1g
transgene, it would give rise to double-mutant embryos (mon;
sup) that were GFP negative but globin positive (GFP-; be3+).
This female would be outcrossed to recover mutations in
suppressor genes.
Using this strategy, we screened about 800 haploid genomes
and identified two recessive suppressor mutants. One of the
mutants is named sunrise (sun), which is an embryonic lethal
mutant with distinctive morphologic phenotypes (Figure 1C).
As shown in Figure 1D, the sun mutant by itself has normal be3
globin expression at 22 hpf but greatly restores be3 expression
in mon mutants. Benzidine staining confirmed that hemoglobin
production was also partially rescued in mon; sun double
mutants (Figure S1 available online).
TheDefectiveGene in SunriseWasMapped to the cdc73
Locus
By positional cloning we mapped the sun gene to chromosome
2 between microsatellite makers z19387 and z13475 (Figure 2A).
This region contains a gene named cdc73, which is a subunit ofCell 142, 133the PAF complex. We noticed that the
morphology of the sun mutant is very
similar to the rtf1/ mutant (Figure 2B),
another subunit in the PAF complex,
including severely reduced body melano-cytes, small ears, impaired blood circulation, and profound peri-
cardial edema (Akanuma et al., 2007). Sequencing of the cdc73
gene in the sun mutant identified a C to T transition at +1507 in
the coding region that leads to a premature stop codon after
amino acid 502 (Figure 2C). This mutation is predicted to cause
a truncated protein missing the last 19 amino acids that are
highly conserved from Drosophila to human (Figure 2D). The
western blot showed a complete loss of CDC73 protein in sun
mutants (Figure 2E), indicating that the truncated protein is
unstable and sun is a null mutant of cdc73.
We further confirmed that injection of wild-type cdc73 mRNA
completely rescued sun mutants (Figure 2B), whereas an anti-
sense morpholino of cdc73 not only phenocopied the sunmutant
(data not shown), but effectively rescued be3 expression in mon
embryos (Figure 2F). In contrast, a control morpholino with five
base-pair mismatches failed to rescue mon. These results
demonstrate that the defective gene in the sun mutant is cdc73.
TIF1g and PAF Antagonistically Regulate Blood Gene
Expression
CDC73 is a component of the PAF complex that also contains
PAF1, RTF1, LEO1, and CTR9 (Mueller and Jaehning, 2002).
To test if other PAF components have similar rescue activity,
antisense morpholinos targeting paf1 or ctr9 were injected into
mon embryos. Knocking down these PAF subunits caused–143, July 9, 2010 ª2010 Elsevier Inc. 135
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Figure 3. TIF1g and PAF Antagonistically Regulate Erythroid Gene Expression
(A) In situ hybridization of be3 showing rescue of mon by depleting other PAF subunits. A 5 bp mismatch control morpholino for ctr9 was used in (vi). Rescue
frequency (%) was shown in (iii–v).
(B) Scheme of using gata1:GFP transgenic line to get RNA from erythroid cells in 12 ss zebrafish embryos.
(C) Real-time RT-PCR analyses to compare the expression of blood genes in GFP+ cells between wild type and morphants. Results are shown as fold change
relative to the wild-type control and normalized to expression of b-actin. The results presented as mean ± standard deviation (SD) from three independent exper-
iments.
(D) Microarray analysis to compare erythroid gene expression in gata1-GFP+ cells from morphants. Left: heat map of 243 erythroid signature genes. Right:
a close-up look of average fold change of top 20% (a) and bottom 20% genes (b) from the heat map on the left. All microarray data have been deposited in
the NCBI’s GEO database under the accession number GSE20432.
See also Figure S2.a sun-like morphological phenotype (data not shown), and
rescued be3 expression in mon (Figure 3A, iv and v). The rtf1/
genetic mutant also rescued globin expression inmon (Figure 3A,
iii). These data suggest that TIF1g antagonizes the whole PAF
complex during blood development.
We next examined the gene expression profiles in tif1g- and
cdc73-deficient cells. To focus on blood-specific targets, we
used gata1:GFP transgenic fish, in which all erythroid cells are
labeled with GFP and therefore can be isolated by fluorescent
activated cell sorting (FACS) (Long et al., 1997). Morpholinos tar-
geted to tif1g or cdc73 were injected into gata1:GFP embryos.
GFP+ cells were isolated at the 12 somite stage (ss) for RNA
extraction (Figure 3B). Quantitative reverse transcription (RT)-
PCR showed downregulation of several blood-specific genes
in tif1g-deficient cells, but their expression was greatly restored
by knocking down cdc73 simultaneously (Figure 3C). Microarray
analyses revealed that among the 243 erythroid-signature genes
that are enriched in gata1:GFP+ cells (L.Z. and G. Weber, unpub-
lished data), many genes were oppositely regulated by tif1g and
cdc73, and the deregulated genes in tif1g-deficient cells are
largely restored in double-knockdown cells (Figure 3D). Notably,
one of the genes regulated by tif1g is scl, the master regulator of136 Cell 142, 133–143, July 9, 2010 ª2010 Elsevier Inc.hematopoiesis. We therefore tested if overexpression of scl
could rescue mon. Injection of scl mRNA clearly increased blood
formation in wild-type embryos but does little in mon mutants
(Figure S2A), suggesting a more direct and broad function of
tif1g in erythropoiesis.
Using quantitative RT-PCR, we also tested other tissue-
specific genes by selecting five to eight representative genes
for each tissue. The tissues we tested include myeloid cells,
muscle, heart, and kidney. We did not see obvious antagonistic
regulation of these genes by tif1g and cdc73 (data not shown).
Among the oppositely regulated genes, genome-wide gene
ontology analysis revealed the enrichment of several pathways,
including BMP signaling pathway and AMP-activated protein
kinase (AMPK) pathway (Figure S2B).
TIF1g Deficiency Reduces the Level of Full-Length
Transcripts of Blood Genes
The PAF complex is involved in multiple steps during transcrip-
tion, including histone 2B ubiquitination, transcription elonga-
tion, and mRNA 30 end processing and polyadenylation
(Penheiter et al., 2005; Rozenblatt-Rosen et al., 2009; Sheldon
et al., 2005; Wood et al., 2003). To determine which function of
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Figure 4. tif1gDeficiency Reduces the Level
of Full-Length Transcripts of Blood Genes
(A) Morpholino knockdown of Rad6 and mRNA
processing factors could not rescue be3 globin
expression in mon. In situ hybridization of be3
globin was performed at 22 hpf. See also
Figure S3.
(B) Top: A schematic diagram showing the position
of primers used in real-time RT-PCR analyses.
Primers to detect the 50 ends of transcripts are
located within 120 bp from transcription start site
(TSS), and primers for the 30 ends of transcripts
are in the 30 coding region or 30 untranslated region
(UTR). Bottom: Real-time RT-PCR analyses to
compare the level of 50 (light pink and light blue)
and 30 (dark pink and dark blue) transcripts of
selected genes between wild-type cells and mor-
pholino knockdown cells. RNA was prepared as
in Figure 3B. Results are shown as average fold
change (mean ± SD) from three independent
experiments, normalized to the level of the 50 tran-
script of b-actin.
(C) TIF1g and CDC73 share common gene targets.
Left: ChIP-Chip in K562 cells revealed a subset of
gene targets shared between TIF1g and CDC73.
The significance of overlapping was evaluated by
a hypergeometric distribution test. Right: ChIP-
Chip at gata1 and gata2 locus. The transcription
direction was indicated by white arrows. The raw
dataset is available on NCBI’s GEO database
under the accession number GSE20428.
(D) TIF1g and CDC73 ChIP in human CD34+ cells
after 5 days of erythroid differentiation (proerythro-
blast stage). Results were normalized to the back-
ground level that was determined by ChIP without
antibody. An inactive gene TRO (tropinin) was
used as the negative control. The results are
shown as mean ± SD from three independent
experiments.
(E) Real-time RT-PCR to compare erythroid gene expression between uninfected and infected CD34+ cells with indicated shRNA constructs. EV: empty vector.
Data are represented as fold change relative to expression levels in uninfected cells. The results are shown as mean ± SD from three independent experiments.PAF contributes to the mon-rescuing effect, we used morpholi-
nos to knock down factors known to interact with PAF during
these processes. Rad6 is an E2 ligase for H2B ubiquitination
and known to be recruited by PAF. We found that knockdown
of the zebrafish Rad6 homologs Rad6A and Rad6B failed to
rescue globin expression in mon (Figure 4A). Similarly, knock-
down of multiple factors essential for 30 RNA processing,
including CPSF2, CPSF3, and CstF2, also failed to rescue mon
(Figure 4A). Western-blot analysis demonstrated near-complete
knockdown of these proteins (Figure S3). These results suggest
pathways other than H2B ubiquitination and 30 RNA processing
are likely to be responsible for rescuing mon upon losing PAF
function.
PAF is thought to promote transcription by positively regu-
lating elongation, yet our results suggested a negative role of
PAF on blood gene expression. To test if loss of tif1g or cdc73
can potentially affect transcription elongation of blood genes
including gata1, scl, be3, and a red-cell membrane protein
epb4.1, we assayed blood gene transcripts near the 50 or 30
end using quantitative RT-PCR (Figure 4B). We detected a similar
level of 50 ends of transcripts in wild-type and tif1g-deficientcells. In contrast, the PCR products from the 30 ends of blood
transcripts were dramatically decreased in tif1g-deficient cells
(Figure 4B). This result could be explained by inefficient Pol II
elongation leading to a reduced level of full-length transcripts,
although this approach mainly measures the steady-state levels
of RNA that are probably released from Pol II. Surprisingly,
depletion of cdc73 greatly restored the level of the 30 ends of
blood transcripts (Figure 4B), suggesting a negative role of
PAF in producing full-length blood transcripts.
TIF1g and CDC73 Share Common Blood Gene Targets
To determine if TIF1g and CDC73 exert their antagonistic roles
by directly binding to blood genes, we performed a small-scale
chromatin immunoprecipitation (ChIP)-Chip analysis for TIF1g
and CDC73 in K562 human erythroleukemia cells using the
Genome Tiling 2.0R Array C. We identified 313 genes bound
by TIF1g and 233 genes bound by CDC73, respectively
(Figure 4C). In total, 129 genes are bound by TIF1g and
CDC73, including several blood-specific genes: gata1, gata2,
runx1, and alas2 (Figure 4C and data not shown). We further
confirmed the binding of TIF1g and CDC73 on these blood genesCell 142, 133–143, July 9, 2010 ª2010 Elsevier Inc. 137
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Figure 5. Effects of FACT, p-TEFb, and DSIF on
Erythropoiesis
(A) Reduced erythropoiesis by inhibiting FACT and
p-TEFb. In situ hybridization of be3 was performed on
22 hpf zebrafish embryos treated with morpholino injection
(ii and iii) or 35 mM flavopiridol (iv). See also Figure S4.
(B) Flavopiridol treatment blocks erythroid differentiation
of human CD34+ cells. Cells were harvested at day 11 after
differentiation (close to terminal differentiation stage),
stained for benzidine (brown), and counterstained with
May-Grunwald (blue).
(C) Similar morphology of sun mutants and spt5
morphants at 36 hpf.
(D) Rescue of mon mutants by spt5 morpholino and
mutants, shown by in situ hybridization of be3 globin at
22 hpf. Note the rescue efficiency was 100% in each
case (ii–iv).in proerythroblasts differentiated from primary human CD34+
cells (Figure 4D). Furthermore, knocking down TIF1g by shRNA
in CD34+ cells reduced the expression of multiple erythroid
genes and severely blocked erythroid differentiation in vitro
(Figure 4E). Two different TIF1g-shRNA constructs showed
similar effects and both efficiently knock down TIF1g at both
the protein level and the mRNA level (Figure 4E and data not
shown). These results demonstrate an evolutionarily conserved
function of TIF1g in eryrthropoiesis.
The Function of PAF-Associated Elongation Factors in
Zebrafish Erythropoiesis
As an elongation factor, PAF has been shown to functionally
interact with other elongation factors, including DSIF, FACT,
and p-TEFb (Qiu et al., 2006; Squazzo et al., 2002). To test if
these factors also play specific roles in hematopoiesis, we
knocked down these PAF-associated elongation factors in ze-
brafish embryos by morpholinos. Knockdown of FACT subunits
SPT16 and SSRP1 diminished globin expression at 22 hpf
(Figure 5A, ii), suggesting that FACT is required for primitive
erythropoiesis. In contrast to a previous study showing that
p-TEFb is not required for primitive hematopoiesis (Meier et al.,
2006), we found that knockdown of CDK9, the kinase subunit
in p-TEFb, disrupted primitive erythropoiesis (Figure 5A, iii). In
addition, treating embryos with flavopiridol, a chemical inhibitor
of CDK9 (Chao and Price, 2001), also inhibited blood formation
(Figure 5A, iv) but left other mesoderm tissues relatively intact
(Figure S4). Moreover, flavopiridol treatment also blocked
erythroid differentiation of human CD34+ cells, as shown by138 Cell 142, 133–143, July 9, 2010 ª2010 Elsevier Inc.benzidine staining in Figure 5B. Taken together,
these results establish that elongation factors
FACT and p-TEFb positively regulate erythro-
poiesis.
In contrast to FACT and p-TEFb, morpholino
knockdown of DSIF subunit SPT5 phenocopied
the morphology of sun mutants (Figure 5C),
suggesting that DSIF and PAF have similar
functions in zebrafish embryos. Furthermore,
depletion of spt5 effectively rescued be3
expression in mon (Figure 5D, ii). To verify themorpholino results, we crossed mon into the spt5s30 mutant
that harbors a deletion of the spt5 gene (Keegan et al., 2002).
Blood was also rescued in mon; spt5s30 double mutants (Fig-
ure 5D, iii). These results suggest that both DSIF and PAF play
negative roles on blood gene expression and TIF1g is required
to antagonize their function.
DSIF has been shown to play dual roles during transcription
elongation (Krishnan et al., 2008). It inhibits elongation by stalling
Pol II at the promoter-proximal region (Chen et al., 2009; Yama-
guchi et al., 2002). To release Pol II, p-TEFb is recruited to the
target gene to phosphorylate Pol II CTD (Cheng and Price,
2007; Wada et al., 1998) and DSIF, and converts DSIF to a posi-
tive elongation factor (Ivanov et al., 2000; Kim and Sharp,
2001; Yamada et al., 2006). To determine which function of
DSIF is responsible for rescuing mon, we tested a hypomorphic
allele spt5m806, which carries a missense mutation leading to
a valine/ aspartic acid change at amino acid 1012 (V1012D).
In vitro transcription studies have shown that the V1012D protein
specifically loses the Pol II pausing ability without affecting the
stimulatory function of SPT5 (Guo et al., 2000). We found that
the spt5m806 hypomorphic mutant was able to rescue be3
expression in mon mutants with the same efficiency as the null
allele spt5s30 (Figure 5D, iv). This result supports the view that
transcription elongation of blood genes in mon mutants is
paused by negative elongation factors, and loss of Pol II pausing
in spt5m806 mutants can restore elongation. This is also consis-
tent with the skewed reduction in the level of 30 ends of blood
gene transcripts by tif1g deficiency (Figure 4B). Because PAF
deficiency can restore the level of full-length transcripts
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Figure 6. TIF1g Is Required to Recruit Positive Elongation Factors to Erythroid Genes
(A) The western blot showing the expression of Flag-tagged human TIF1g in stably transfected K562 cells. Red asterisk: Flag-tagged h TIF1g. Black asterisk:
endogenous hTIF1g.
(B) Colloidal Coomassie blue staining showing proteins pulled down by anti-Flag antibody from untransfected K562 cells and cells stably expressing Flag-tagged
TIF1g. Flag-tagged TIF1g is indicated by a red asterisk.
(C) The factors from the SCL complex and the FACT complex identified in the MS analyses following anti-Flag pull down. The numbers of peptides were summa-
rized from six independent experiments. See also Table S1.
(D) K562 nuclear extracts were immunoprecipitated (IP) and subsequently immunoblotted (IB) with indicated antibodies. Corresponding IgG was used as the
negative control. Note CDC73 and SPT5 do not co-IP with TIF1g or SCL. DDX17 was used as a negative control to show the specificity of co-IP experiments.
See also Figure S5.
(E) CDK9 ChIP in human CD34+ cells infected with empty vector (EV) or tif1g-shRNAs. Cells were harvested after 5 days of erythroid differentiation (proerythro-
blast stage). Results are shown as fold enrichment compared to the background level that is determined by no-antibody ChIP. The results are shown as
mean ± SD from two independent experiments.(Figure 4B), we suspect that PAF may behave similarly as DSIF
to negatively regulate elongation by stalling Pol II on blood
genes.
TIF1g Physically Associates with FACT, p-TEFb,
and the SCL Complex
Both TIF1g and elongation factors are ubiquitously expressed
proteins yet play specific roles in erythroid gene expression.
To elucidate the mechanism that determines this cell specificity,
we performed a pull-down assay to identify the blood-specific
binding partners of TIF1g. We made a stable cell line expressing
Flag-tagged human TIF1g by transfecting K562 human erythro-
leukemia cells (Figure 6A). Flag pull-down assay followed by
mass spectrometry (MS) revealed many blood-specific tran-
scription factors and cofactors that bind to Flag-tagged TIFg
(Figures 6B and 6C; Table S1), including SCL, LDB1, HEB, and
other factors known to associate with SCL. We classified these
proteins into the group of ‘‘the SCL complex.’’ The finding of
blood-specific transcription factors coupled to TIF1g establishes
a mechanism by which TIF1g exerts blood-specific regulation of
transcription.Surprisingly, the most abundant proteins pulled down with
Flag-tagged TIF1g were SPT16 and SSRP1, the two subunits
of the FACT complex. To verify the MS results, we performed
coimmunoprecipitation experiments using endogenous proteins
from untransfected K562 cells (Figure 6D). TIF1g, SCL, and
SPT16 can reciprocally immunoprecipitate with one another,
confirming interactions among the endogenous proteins.
Although MS did not identify p-TEFb subunits in the pull-down
assay, we found that p-TEFb subunit CDK9 coimmunoprecipi-
tated with TIF1g, SCL, and SPT16, and vice versa (Figure 6D),
suggesting p-TEFb as an endogenous interacting partner of
TIF1g and SCL. Gel-filtration assays revealed a coelution of
these proteins (Figure S5), suggesting that these proteins may
exist in the same complex. These data demonstrate that TIF1g
interacts, directly or indirectly, with the SCL, FACT, and pTEFb
complexes. In contrast, we did not find interactions of the PAF
and DSIF components CDC73 and SPT5 with TIF1g and SCL
(Figure 6D).
A hypothesis from the interaction data is that TIF1gmay recruit
elongation factors p-TEFb and FACT to blood genes. To test this
hypothesis, we performed ChIP analysis on CDK9 in humanCell 142, 133–143, July 9, 2010 ª2010 Elsevier Inc. 139
Figure 7. Model of TIF1g Regulating Transcription Elongation of
Blood Genes
In wild-type blood cells, Pol II elongation on blood-specific genes is inhibited
by PAF and DSIF. TIF1g is required to release paused Pol II by recruiting
p-TEFb and FACT to blood genes through interacting with the SCL complex.
The kinase activity of p-TEFb phosphorylates DSIF and Pol II CTD.
Phosphorylated Pol II then proceeds to finish elongation. In mon mutant blood
cells, recruitment of p-TEFb and FACT is not efficient in the absence of TIF1g,
which in turn affects Pol II phosphorylation and releasing from the paused
state, resulting in elongation blockage. In double-mutant cells missing both
TIF1g and DSIF/PAF, Pol II is no longer paused, elongation will continue
even without help from positive elongation factors.CD34+ cells under erythroid differentiation. In control cells, we
detected an enriched occupancy of CDK9 on several blood
genes, including gata1, gata2, runx1, and alas2 (Figure 6E);
however, this enrichment was dramatically decreased upon
knocking down tif1g by shRNA (Figure 6E). The two tif1g-shRNA
constructs showed similar effect. These data support a TIF1g-
dependent recruitment of p-TEFb to erythroid genes, although
we could not assess the recruitment of FACT due to the lack of
ChIP-grade antibody. Together with the genetic results, we
propose that TIF1g promotes blood gene transcription by
recruiting positive elongation factors such as p-TEFb to coun-
teract negative factors that pause Pol II. In the absence of Pol
II pausing (such as in DSIF or PAF-deficient cells), transcription
of blood genes can bypass the requirement of TIF1g.DISCUSSION
Cell fate specification at the transcription level involves a
series of molecular steps. Transcription initiation is regulated
by cell-specific DNA-binding proteins that associate with chro-
matin factors and recruit Pol II to promoters. After Pol II is
engaged, transcription pausing occurs commonly. The reason140 Cell 142, 133–143, July 9, 2010 ª2010 Elsevier Inc.why pausing exists, and its role in organogenesis, remain
unclear. To release paused Pol II, positive elongation factors are
recruited by cell-specific factors. The work presented here high-
lights the required coordination of all aspects of transcription
within a cell lineage including initiation, pausing, and elongation.
Genetic Suppressor Screens in Zebrafish
The zebrafish is a powerful model organism for the study of
vertebrate genetics. Many zebrafish mutants define critical steps
of organogenesis and are excellent models of human diseases.
Performing suppressor screens on these mutants will be very
useful to identify interacting pathways that may have clinical
implications. Unfortunately, many mutants are embryonic lethal,
making suppressor screens practically difficult. Our work here
provides a foundation for undertaking genetic suppressor
screens in zebrafish and making use of the powerful haploid
genetics. The BAC rescue approach leads to viable fish with
a homozygous lethal mutation available in large numbers, and
the linkage of GFP on the BAC distinguishes the transgenic
mutants from nontransgenic mutants. The haploid genetics in
zebrafish allows for an adequate number of recessive mutants
to be identified in the F1 generation. To our knowledge, this is
the first genetic suppressor screen performed in zebrafish.
A Model of TIF1g Regulating Transcription Elongation
Our study suggests a role of TIF1g in regulating transcription
elongation of erythroid genes: (1) Multiple elongation factors,
including PAF, DSIF, FACT, and p-TEFb, specifically affect blood
gene expression (either positively or negatively). (2) TIF1g phys-
ically associates with positive elongation factors p-TEFb and
FACT. (3) Recruitment of p-TEFb to blood genes is interrupted
in tif1g-deficient cells. (4) Loss of Pol II pausing activity in spt5
hypomorphic mutant is sufficient to rescue blood gene expres-
sion in tif1g mutant animals.
As shown in Figure 7, we propose a model in which TIF1g
functionally links positive elongation factors to blood-specific
transcription complexes to regulate transcriptional elongation
of blood genes by antagonizing Pol II pausing. In wild-type blood
cells, TIF1g is required to counteract Pol II pausing factors by
recruiting p-TEFb (and possibly FACT as well) to blood genes
through interacting with the SCL complex. Lack of TIF1g disrupts
the recruitment of p-TEFb and FACT, resulting in elongation
blockage. In double-mutant cells missing both TIF1g and
pausing factors (such as DSIF and PAF), Pol II is no longer
paused, elongation may continue even without help from posi-
tive elongation factors. Consistent with this model, a previous
study in C. elegans showed that spt5 mutants could bypass
the requirement of p-TEFb to turn on heatshock gene expression
(Shim et al., 2002). Our model predicts that Pol II should be
concentrated on blood-specific promoters in tif1g mutant cells,
but should be released into the gene body in double-mutant
cells. Due to technical limitations, we currently have not exam-
ined Pol II occupancy on erythroid genes in the tif1g mutant to
directly establish whether Pol II is paused in the mutant.
Function of PAF in Transcription Elongation
The rescue of tif1g mutants by the loss of inhibitory function of
DSIF establishes a major function of TIF1g in counteracting Pol II
pausing. Unlike DSIF, PAF was shown as a positive elongation
factor in previous studies. To our knowledge, our work is the first
example suggesting a negative role of PAF during elongation.
PAF is known to associate with elongating Pol II and plays an
important role in H2B ubiquitination, which is a hallmark of active
transcription. However, a recent study has suggested that H2B
ubiquitination does not directly affect the activity of the transcrip-
tional machinery, but rather exists as a consequence of tran-
scription (Kim et al., 2009). In light of this view, we found that
depletion of the H2B ubiquitination enzyme Rad6 could not
rescue mon. In addition, PAF is known to physically interact
with 30 RNA processing factors to regulate polyadenylation;
however, morpholino knockdown of polyadenylation factors
showed no similarity to PAF mutants (Figure S3A). Instead we
found that PAF mutants and DSIF mutants behave similarly in
terms of morphological defects and the ability to rescue tif1g-
deificient blood defects. Depletion of PAF restored production
of full-length blood gene transcripts in mon mutants, suggesting
a negative function of PAF during elongation. We suspect that
PAF may also have dual functions similar to DSIF, which inhibits
Pol II progression at the early elongation stage but then is con-
verted to a positive factor and travels with elongating Pol II.
NELF is another pausing factor but in our hands, depletion of
NELF subunits did not cause DSIF/PAF-like phenotypes and
also failed to rescue blood in mon (data not shown), suggesting
a NELF-independent mechanism in our system.
Regulation of Pausing as a Cell-Specific Developmental
Checkpoint
Pol II pausing is predominantly found on the genes involved in
signaling transduction and developmental regulation (Zeitlinger
et al., 2007). An advantage of having paused Pol II at the
promoter proximity is to allow a rapid and synchronized activa-
tion of gene expression upon developmental or environmental
stimuli. Blood development is a very dynamic process and
multiple signals cooperate to control cell proliferation and dif-
ferentiation. The erythroid lineage is particularly sensitive to
environmental stress and responds by rapid proliferation/differ-
entiation to maintain red cell homeostasis. One hypothesis is
that erythroid precursors use paused elongation to coordinate
gene expression in response to external stimuli.
We propose that transcriptional pausing may function as
a developmental checkpoint for erythroid cell differentiation.
Loss of this checkpoint in PAF and DSIF mutants has no major
effect on erythroid differentiation. Only under certain conditions
where elongation is disrupted, such as inmonmutants, the effect
of pausing is detected. This is similar to a tumor suppressor
pathway that is activated only in certain situations such as
DNA damage and represents a checkpoint of the cell cycle.
The cell-specific nature of the mon mutant is remarkable. We
propose that the SCL complex provides a cell-specific regulation
of elongation, in the same way that it regulates the cell specificity
of transcription initiation. The enriched tif1g expression in
erythroid cells may represent an evolutionary selection of
utilizing the special role of TIF1g in erythroid cells.
It remains a question which signaling pathways control the
transcription elongation of blood genes. Previous studies have
found interactions between TIF1g and TGFb/BMP pathways,albeit with contradictory results (Dupont et al., 2005, 2009;
He et al., 2006). In our TIF1g pull-down assays, both Smad2
and Smad4 proteins were detected with only a few peptides
(Table S1). Although tif1g-deficient animals do not resemble
mutants in TGFb/BMP pathways, our data do not exclude the
possibility that either pathway may contribute to TIF1g-depen-
dent elongation regulation in hematopoiesis. BMP signaling is
involved in stress-induced erythropoiesis (Lenox et al., 2005;
Perry et al., 2007). In this respect, it is interesting to note that
our microarray analysis identified the BMP pathway as the
most represented signaling pathway oppositely regulated by
tif1g and cdc73 (Figure S2B).
Our findings provide a checkpoint mechanism for coordinated
cell differentiation during organogenesis. If external signals are
not available or cell-specific intrinsic regulators are not fully
assembled, the cell can use the Pol II pausing mechanism to
temporarily stall transcription while maintaining cell identity
and viability. Relief of the pause by factors such as TIF1g ensures
a rapid and perhaps synchronized response to differentiation
signals.EXPERIMENTAL PROCEDURES
Zebrafish Maintenance, Transgenesis, and Haploid Screen
Zebrafish were maintained in accordance with Animal Research Guidelines at
Children’s Hospital Boston. The BAC construct was injected into one-cell-
stage embryos from mon heterozygote intercrosses to generate mon; Tg
{Tif1g+; bactin:GFP} stable lines. ENU mutagenesis and haploid screen were
performed as previously described (Solnica-Krezel et al., 1994; Shepard
et al., 2005, #73). Haploid embryos at 22 hpf were used for double in situ
hybridization of GFP and be3. Females giving rise to at least 10% embryos
with a GFP-; be3+ pattern were considered carrying the suppressor mutation
and outcrossed with wild-type transgenic males, and F2 diploid intercrosses
were performed to verify the mutants. See the Extended Experimental Proce-
dures for detailed description of BAC transgene construction and genetic
mapping.Morpholino Injection
Morpholinos were obtained from Gene Tools, LLC, and injected into one to
four cell-stage embryos. See the Extended Experimental Procedures and
Table S2 for morpholino sequences and working concentrations.Microarray and ChIP Analyses
Microarray hybridization was performed at Roche Nimblegen (Reykjavı´k,
Iceland) using Nimblegen zebrafish expression arrays. The goldenspike
package in Bioconductor/R (Choe et al., 2005) was used to process CEL files
and identify genes with relative changes of mRNA levels between wild-type
and morphants. A log2 mean fold change was calculated along with a q value.
Ingenuity Pathway Analysis Software (http://www.ingenuity.com) was used for
genome-wide gene ontology analysis.
ChIP reactions were performed as described previously (Kim et al., 2008)
with 1:100 dilution of individual antibody. Approximately 3 to 5 3 107 cells
were used for each antibody. CHIP hybridizations were performed at Dana-
Farber Microarray Core Facility using the Human Genome Tiling 2.0R Array
C that contains chromosomes 3, 21, 22, X, and Y. Model-based analysis of
tiling array (MAT) (Johnson et al., 2006) was applied to predict the target
loci. The raw dataset is available on the National Center for Biotechnology
Information (NCBI)’s Gene Expression Omnibus database under the accession
number GSE20428. For ChIP-PCR analysis, the ChIP samples were analyzed
by real-time quantitative PCR (BioRad). All primers were tested for PCR effi-
ciency as recommended by the manufacturer (BioRad). See the Extended
Experimental Procedures for primer sequences.Cell 142, 133–143, July 9, 2010 ª2010 Elsevier Inc. 141
shRNA Knockdowns in Human CD34+ Cells
Primary human CD34+ cells were obtained from the Yale Center of Excellence
in Molecular Hematology (YCEMH). shRNA clones in the puromycin-resistant
pLKO vector were obtained from Sigma. The empty vector pLKO.1 was used
to produce control lentiviruses. Lentiviruses were prepared and infection of
cells was carried out as described (Moffat et al., 2006). Selection with puro-
mycin (1 mg/ml) was initiated at 48 hr following infection, which corresponded
to the time when the cells were seeded into differentiation medium. See the
Extended Experimental Procedures for cell culture condition and shRNA
sequences.
Plasmid Construction and K562 Cell Transfection
The cDNA encoding human TIF1g excluding the start ATG, was cloned in
frame into the pEF-FLAG-Biotag vector (Woo et al., 2008) to generate an
amino-terminal FLAG fusion molecule. K562 cells were transfected by electro-
poration with pEF-FLAG-TIF1g construct, cultured in 96-well plates containing
medium with 1 mg/ml puromycin to select single clones.
Flag Pull-Down Assays and MS
Nuclear extract was prepared from 1 3 1010 cells as previously described
(Woo et al., 2008). Approximately 50 to 120 mg of total nuclear protein was
incubated with anti-FLAG M2-agarose beads (Sigma) overnight. After wash,
bound proteins were eluted with 0.1 mg/ml FLAG peptide (Sigma) and concen-
trated by trichloroacetic acid precipitation. Precipitated proteins were
resolved on 10% SDS-PAGE and visualized with Colloidal Coomassie blue
stain (Invitrogen). The excised acrylamide gel sections were used for MS con-
ducted at Taplin Biological Mass Spectrometry Facility of Harvard Medical
School.
Antibodies for Coimmunoprecipitation and ChIP
See the Extended Experimental Procedures for a list of antibodies.ACCESSION NUMBERS
All microarray data have been deposited in the Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo) under the accession number GSE20432.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and two tables and can be found with this article online at doi:10.
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